Peritoneal dissemination in early gastric cancer: importance of the lymphatic route

被引:0
作者
Masao Yoshida
Takashi Sugino
Kimihide Kusafuka
Takashi Nakajima
Rie Makuuchi
Masanori Tokunaga
Yutaka Tanizawa
Etsuro Bando
Taiichi Kawamura
Masanori Terashima
Noboru Kawata
Masaki Tanaka
Naomi Kakushima
Kohei Takizawa
Hiroyuki Ono
机构
[1] Shizuoka Cancer Center,Division of Pathology
[2] Shizuoka Cancer Center,Division of Endoscopy
[3] Shizuoka Cancer Center,Division of Gastric Surgery
来源
Virchows Archiv | 2016年 / 469卷
关键词
Gastric cancer; Neoplastic processes; Neoplasm seeding; Lymphatic metastasis; Lymphatic vessels;
D O I
暂无
中图分类号
学科分类号
摘要
The current paradigm concerning the mechanism of peritoneal dissemination of gastric cancer is that it occurs through an invasive process in which cancer cells directly penetrate the gastric wall and exfoliate into the peritoneal cavity. However, some experimental studies suggest the lymphatic route as an alternative. We present five early gastric cancer cases, which support this alternative pathway of peritoneal dissemination without direct invasion in the serosa. We investigated all patients with early gastric cancer who underwent curative gastrectomy between September 2002 and February 2015 at the Shizuoka Cancer Center, Japan. We examined them by intraoperative peritoneal lavage cytology and frozen section diagnosis of peritoneal nodules during laparotomy. Peritoneal dissemination was defined as peritoneal metastasis by positive cytology or histological diagnosis. Among 1509 early gastric cancers, five cases (0.3 %, 95 % CI 0.1–0.8 %) presented peritoneal dissemination detected by lavage cytology and frozen section diagnosis of peritoneal nodules. Histological examination revealed that the primary tumors invaded the submucosal layer using the lymphatic route, through which they metastasized to regional lymph nodes. Our data indicate that gastric cancer may give rise to peritoneal dissemination even at an early stage, probably through the lymphatic route without direct invasion into the serosa.
引用
收藏
页码:155 / 161
页数:6
相关论文
共 222 条
[1]  
Jemal A(2011)Global cancer statistics CA Cancer J Clin 61 69-90
[2]  
Bray F(1990)Gastric cancer: a 25-year review Br J Surg 77 353-1321
[3]  
Center MM(2011)Past and present achievements, and future direction of the Gastrointestinal Oncology Study Group (GIOSG), a Division of Japan Clinical Oncology Group (JCOG) Jpn J Clin Oncol 41 1315-628
[4]  
Ferlay J(2014)Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors Int J Cancer 134 622-262
[5]  
Ward E(1999)Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma Am J Surg 178 256-697
[6]  
Forman D(2010)Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial Lancet (London, England) 376 687-267
[7]  
Allum WH(1997)Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer J Clin Oncol 15 261-3209
[8]  
Fielding JW(2010)Chemotherapy for advanced gastric cancer Cochrane Database Syst Rev 3 CD004064-1581
[9]  
Boku N(2007)Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: the V-325 Study Group J Clin Oncol 25 3205-698
[10]  
Thomassen I(2011)Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial Ann Surg Oncol 18 1575-633